Amelia Rodrock alias The Root-Cause Rib

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure neuropathy.

neuropathy

Supports

High-quality guidelines for neuropathy, especially diabetic peripheral neuropathy, explicitly distinguish between 1) modifying underlying risk factors and disease processes and 2) symptomatic pain control, which conceptually aligns with “addressing root causes” rather than only masking symptoms.^[10][14] For diabetic neuropathy, major guidelines recommend intensive glycemic control, optimization of blood pressure, lipids, weight, and lifestyle modification to prevent onset and slow progression of neuropathy, which are disease-modifying strategies aimed at underlying pathophysiology rather than pure symptom masking.^[7][10][14] In chemotherapy-induced peripheral neuropathy (CIPN), authoritative oncology guidelines recommend adjusting or stopping neurotoxic chemotherapy (dose reduction, delay, substitution, or discontinuation) when neuropathy occurs; this is a causal, upstream intervention on the primary cause of neuropathy rather than symptomatic treatment alone.^[16] There is growing evidence that structured exercise programs can reduce CIPN symptom scores, improve balance and quality of life in patients receiving neurotoxic chemotherapy, which functions as a supportive, partially disease-modifying or compensatory approach rather than purely analgesic masking.^{[0][21][22][24]} Recent reviews and clinical compendia for diabetic neuropathy describe management as having three pillars, where the first is “causal treatment” (near-normoglycemia, cardiovascular risk-factor intervention, lifestyle changes), explicitly framed as targeting the causes of neuropathy rather than only its pain.^[14]

Contradicts

Despite recognition of upstream or causal interventions, the bulk of high-quality evidence and guideline recommendations for established peripheral neuropathy—both diabetic and chemotherapy-induced—focus on pharmacologic agents (gabapentinoids, SNRIs such as duloxetine, tricyclic antidepressants, sodium-channel blockers) that primarily provide symptomatic pain relief and do not reliably reverse the underlying nerve damage, indicating that most effective, evidence-based treatments still “mask” or palliate symptoms.^{[3][4][10][11][12][13][15]} For CIPN, major oncology guidelines state that no pharmacologic agent has proven effective for prevention, and duloxetine is the only medication with adequate evidence for treatment of established painful CIPN, and even then the benefit is described as limited, which argues against the existence of broadly effective root-cause-directed medical therapies that resolve CIPN.^[16][23] Systematic reviews of duloxetine in CIPN report only modest or uncertain efficacy and do not demonstrate reversal of nerve pathology, reinforcing that treatment remains largely symptomatic.^[16][23] For diabetic peripheral neuropathy, although glycemic and risk-factor control can prevent onset or slow progression, they are far less effective at reversing chronic neuropathy once present, so for many patients the realistic evidence-based strategy is risk-factor optimization plus symptomatic pain control rather than a curative “root cause” treatment.^{[4][7][10][14]} No high-quality guidelines or systematic reviews were identified that support broad, clinic-branded claims that a single center or program can reliably “treat neuropathy by addressing root causes” in a way that consistently goes beyond the standard combination of risk-factor management, lifestyle measures, and conventional symptomatic pharmacotherapy. The available evidence instead supports a multi-pronged but still limited approach rather than a comprehensive root-cause cure.^{[4][10][12][14][16]}

Mainstream view

Mainstream medical consensus is that peripheral neuropathy is a heterogeneous group of conditions (e.g., diabetic, chemotherapy-induced, drug-induced, hereditary, nutritional, toxic), and management should include both 1) attempts to address modifiable upstream causes where possible (improving glycemic control, correcting nutritional deficiencies, adjusting or stopping offending drugs, managing cardiovascular risk factors, promoting exercise and other lifestyle measures), and 2) evidence-based symptomatic treatment of neuropathic pain and functional impairment using medications such as gabapentinoids, SNRIs, tricyclic antidepressants, topical agents, and nonpharmacologic modalities.^{[4][6][7][10][11][12][14][16]} Guidelines for diabetic peripheral neuropathy emphasize prevention and slowing progression through metabolic and cardiovascular risk-factor control, while acknowledging that many patients will still require long-term symptomatic pain management and that reversal of established neuropathy is uncommon.^{[4][7][10][14]} Guidelines for chemotherapy-induced peripheral neuropathy stress that no proven preventive pharmacologic agents exist, that modification of chemotherapy regimens is the main causal strategy, and that duloxetine offers limited symptomatic benefit when painful CIPN is established, often alongside supportive exercise or rehabilitation interventions.^{[0][16][20][21][24]} Overall, the prevailing view is that clinicians should address known modifiable causes

In their own wordsView sourceArchived copy

“Neuropathy”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Neuropathy

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure physical therapy.

physical therapy

Supports

The influencer’s claim is vague, but the core interpretable idea is that chiropractic treatment (especially spinal manipulative therapy) can serve as a therapeutic intervention for musculoskeletal pain in a way comparable to or overlapping with physical therapy. ^[8] High-quality evidence supports that spinal manipulation, a key component of chiropractic care, can reduce pain and improve function in low back pain, which is also a common focus of physical therapy. ^[10] A systematic review and meta-analysis of randomized controlled trials on spinal manipulative therapy for chronic low back pain found that manipulation yields pain and disability outcomes similar to other recommended therapies such as exercise programs, which are core physical therapy interventions. ^[15] This supports that chiropractic manipulation is a reasonable conservative option within a multidisciplinary or guideline-informed management of chronic low back pain, not clearly inferior to standard PT-type exercise approaches. ^[5] The WHO-informed systematic review on structured exercise programs for chronic primary low back pain shows that structured exercise has clinically important benefits in pain and function. ^[11][12] Together with the SMT meta-analysis, this indicates both PT-style exercise and chiropractic manipulation are effective conservative treatments. Clinical practice guidelines specifically for chiropractic care in low back pain conclude that doctors of chiropractic are suited to diagnose, treat, and co‑manage patients with low back pain, and recommend spinal manipulative therapy as one option among conservative treatments, often in combination with exercise and patient education. ^{[6][13][14][16]} There are randomized controlled trials showing that chiropractic spinal manipulation can reduce pain and disability in acute and subacute low back pain, sometimes outperforming placebo or certain medications, and producing similar or modestly better outcomes than other conservative approaches over the short term. Overall, high‑quality evidence supports that chiropractic care, particularly spinal manipulation, can improve pain and function in low back pain and can be used in a similar therapeutic domain as physical therapy (conservative musculoskeletal care), although not as a replacement for all PT modalities.

Contradicts

The claim as stated does not specify whether chiropractic is being promoted as superior to, equivalent to, or a replacement for physical therapy; evidence does not support strong superiority or a blanket replacement. ^[10] Where direct comparisons have been made, systematic reviews of chiropractic spinal manipulation versus standard physical therapy for musculoskeletal pain generally find that both interventions are largely equivalent in effectiveness for pain reduction and functional improvement, with no consistent long‑term superiority of chiropractic over PT. ^{[13][14][15][16]} The high‑quality SMT meta-analysis for chronic low back pain shows effects similar to other recommended therapies, not uniquely superior. This contradicts any implication that chiropractic treatment is categorically better than physical therapy. Evidence for manipulation is condition‑specific and most robust for low back pain; it is weaker or more uncertain for other musculoskeletal and non‑musculoskeletal conditions. Promoting chiropractic treatment as broadly effective for diverse conditions in the way physical therapy addresses post‑operative rehab, neurological conditions, and cardiopulmonary rehabilitation is not supported. ^[8] The WHO‑informing systematic review on structured exercise programs for chronic primary low back pain underscores exercise (a core PT modality) as beneficial and guideline‑supported. ^[11][12] There is no high‑quality evidence showing that chiropractic manipulation alone is superior to such structured PT programs across outcomes or time horizons. Some randomized trials find only modest or short‑term benefits of manipulation, and others show similar improvements in both active and sham manipulation groups, indicating a substantial non‑specific or placebo component, which weakens claims of strong mechanistic or long‑term superiority over PT. Overall, the evidence contradicts strong or exclusive claims that chiropractic treatment is more effective than physical therapy, or that it should replace physical therapy for most patients.

Mainstream view

Mainstream medical and rehabilitation practice views chiropractic spinal manipulation as one of several conservative options for mechanical low back pain and some other musculoskeletal complaints, with benefits broadly comparable to recommended therapies such as structured exercise, as used in physical therapy. ^{[11][12][13][14][15][16]} Major guidelines for low back pain management prioritize non‑pharmacologic conservative care that includes exercise therapy, education, and sometimes spinal manipulation, typically recommending that any of these be chosen based on patient preference, access, and comorbidities rather than asserting one clearly superior modality. ^[5][6] Physical therapy is regarded as a core, broadly applicable discipline for musculoskeletal, neurological, and cardiopulmonary rehabilitation, supported by extensive evidence for structured exercise and functional training. Chiropractic care is viewed as more narrowly focused, primarily around spinal and joint manipulation and related conservative measures. The mainstream position is that chiropractic

In their own wordsView sourceArchived copy

“physical therapy”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise We don’t just treat symptoms, we uncover the root cause of pain as within their scope of practice.

We don’t just treat symptoms, we uncover the root cause of pain

Supports

Major clinical guidelines generally emphasize diagnosis and pathophysiology, not just symptom relief, and recommend targeting underlying disease mechanisms where they are known. ^[6] For example, modern hypertension management guidelines focus on sustained blood pressure control to reduce long‑term cardiovascular risk (the disease process), not only immediate relief of symptoms, and base treatment on etiologic and risk‑factor assessment such as renal disease, diabetes, and lifestyle factors. ^[5][10][17] In inflammatory bowel disease, ESPEN nutrition guidelines recommend systematic assessment of disease activity, malnutrition, and complications, then tailoring enteral or parenteral nutrition to correct underlying deficiencies and metabolic derangements rather than simply treating fatigue or weight loss as isolated symptoms. ^[7][9] Parenteral nutrition guidelines likewise stress identifying when gut function is inadequate and clarifying the underlying reason for nutritional failure—short bowel, obstruction, severe malabsorption—before initiating PN, thereby addressing the root cause of poor oral intake. Evidence‑based headache guidelines for tension‑type headache advocate evaluating secondary causes, comorbid anxiety or depression, and medication overuse, and incorporating preventive and non‑pharmacologic strategies (e. ^[8] g. , stress management, physiotherapy) that target triggers and pathophysiological contributors, not only acute pain relief. Colchicine use in pericarditis is based on evidence that it reduces recurrence by modulating the inflammatory process in the pericardium, which is closer to targeting a root mechanism than merely relieving chest pain. ^[18] Across these examples, mainstream practice frameworks (e. g. , GRADE) explicitly encourage linking interventions to plausible causal pathways and clinically meaningful outcomes, which conceptually aligns with the idea of looking beyond symptoms to underlying mechanisms.

Contradicts

Although guidelines aim to base treatment on disease mechanisms when known, they do not support the notion that clinicians can always reliably "uncover the root cause" of pain or other symptoms. ^[6] Many conditions, including tension‑type headache, have multifactorial or incompletely understood causes, and the EFNS guideline acknowledges the limited ability to identify a single definitive cause in many patients; management is therefore largely symptomatic and preventive rather than truly causal. ^[5][8] Hypertension guidelines note that most adult hypertension is primary (essential), meaning no specific reversible root cause is identifiable; treatment focuses on risk reduction and blood pressure control instead of curing an underlying single cause. In inflammatory bowel disease, ESPEN guidelines highlight that nutrition support addresses consequences (malnutrition, weight loss, micronutrient deficits) rather than the primary immunologic and genetic drivers of disease, so it cannot be described as fully treating the root cause. ^[7] Parenteral nutrition and blood transfusion are prototypical supportive therapies: PN corrects nutrient delivery and transfusion corrects anemia or coagulopathy but do not resolve the fundamental disease processes (e. ^[9][17] g. , IBD, malignancy, bone‑marrow failure). Overall, major guidelines use cautious language about mechanisms, emphasize uncertainty and imprecision in evidence grading, and do not claim routine, consistent discovery of root causes for complex symptoms such as chronic pain. ^[10]

Mainstream view

The mainstream medical position is that clinicians aim to make an etiologic diagnosis and understand pathophysiology when possible, but in many domains—especially chronic pain, headaches, and multifactorial syndromes—only partial mechanisms are known and treatment often focuses on a combination of symptom relief, risk reduction, and management of contributing factors rather than a single root cause. ^[8] Hypertension, for instance, is predominantly essential, so guideline‑driven care is framed around evidence‑based blood pressure targets and risk stratification rather than identifying a discrete reversible cause in most patients. ^[5][17] In inflammatory bowel disease and in patients requiring parenteral nutrition, mainstream practice uses structured assessment and targeted interventions to address disease consequences and modifiable contributors, while acknowledging that underlying immune and genetic drivers remain. ^[7][9] Headache and pain guidelines encourage evaluation for secondary causes and psychosocial contributors but recognize that definitive root causes are frequently unavailable, making a balanced approach that includes symptomatic management, prevention, and risk mitigation standard of care. ^[6] Evidence frameworks such as GRADE explicitly highlight imprecision and uncertainty, reinforcing that strong mechanistic claims must be supported by high‑quality data and should avoid promising universal identification of root causes. ^[10]

In their own wordsView sourceArchived copy

“We don’t just treat symptoms, we uncover the root cause of pain”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms.

At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms

Supports

High-quality guidelines for neuropathy, especially diabetic peripheral neuropathy, explicitly distinguish between 1) modifying underlying risk factors and disease processes and 2) symptomatic pain control, which conceptually aligns with “addressing root causes” rather than only masking symptoms.^[10][14] For diabetic neuropathy, major guidelines recommend intensive glycemic control, optimization of blood pressure, lipids, weight, and lifestyle modification to prevent onset and slow progression of neuropathy, which are disease-modifying strategies aimed at underlying pathophysiology rather than pure symptom masking.^[7][10][14] In chemotherapy-induced peripheral neuropathy (CIPN), authoritative oncology guidelines recommend adjusting or stopping neurotoxic chemotherapy (dose reduction, delay, substitution, or discontinuation) when neuropathy occurs; this is a causal, upstream intervention on the primary cause of neuropathy rather than symptomatic treatment alone.^[16] There is growing evidence that structured exercise programs can reduce CIPN symptom scores, improve balance and quality of life in patients receiving neurotoxic chemotherapy, which functions as a supportive, partially disease-modifying or compensatory approach rather than purely analgesic masking.^{[0][21][22][24]} Recent reviews and clinical compendia for diabetic neuropathy describe management as having three pillars, where the first is “causal treatment” (near-normoglycemia, cardiovascular risk-factor intervention, lifestyle changes), explicitly framed as targeting the causes of neuropathy rather than only its pain.^[14]

Contradicts

Despite recognition of upstream or causal interventions, the bulk of high-quality evidence and guideline recommendations for established peripheral neuropathy—both diabetic and chemotherapy-induced—focus on pharmacologic agents (gabapentinoids, SNRIs such as duloxetine, tricyclic antidepressants, sodium-channel blockers) that primarily provide symptomatic pain relief and do not reliably reverse the underlying nerve damage, indicating that most effective, evidence-based treatments still “mask” or palliate symptoms.^{[3][4][10][11][12][13][15]} For CIPN, major oncology guidelines state that no pharmacologic agent has proven effective for prevention, and duloxetine is the only medication with adequate evidence for treatment of established painful CIPN, and even then the benefit is described as limited, which argues against the existence of broadly effective root-cause-directed medical therapies that resolve CIPN.^[16][23] Systematic reviews of duloxetine in CIPN report only modest or uncertain efficacy and do not demonstrate reversal of nerve pathology, reinforcing that treatment remains largely symptomatic.^[16][23] For diabetic peripheral neuropathy, although glycemic and risk-factor control can prevent onset or slow progression, they are far less effective at reversing chronic neuropathy once present, so for many patients the realistic evidence-based strategy is risk-factor optimization plus symptomatic pain control rather than a curative “root cause” treatment.^{[4][7][10][14]} No high-quality guidelines or systematic reviews were identified that support broad, clinic-branded claims that a single center or program can reliably “treat neuropathy by addressing root causes” in a way that consistently goes beyond the standard combination of risk-factor management, lifestyle measures, and conventional symptomatic pharmacotherapy. The available evidence instead supports a multi-pronged but still limited approach rather than a comprehensive root-cause cure.^{[4][10][12][14][16]}

Mainstream view

Mainstream medical consensus is that peripheral neuropathy is a heterogeneous group of conditions (e.g., diabetic, chemotherapy-induced, drug-induced, hereditary, nutritional, toxic), and management should include both 1) attempts to address modifiable upstream causes where possible (improving glycemic control, correcting nutritional deficiencies, adjusting or stopping offending drugs, managing cardiovascular risk factors, promoting exercise and other lifestyle measures), and 2) evidence-based symptomatic treatment of neuropathic pain and functional impairment using medications such as gabapentinoids, SNRIs, tricyclic antidepressants, topical agents, and nonpharmacologic modalities.^{[4][6][7][10][11][12][14][16]} Guidelines for diabetic peripheral neuropathy emphasize prevention and slowing progression through metabolic and cardiovascular risk-factor control, while acknowledging that many patients will still require long-term symptomatic pain management and that reversal of established neuropathy is uncommon.^{[4][7][10][14]} Guidelines for chemotherapy-induced peripheral neuropathy stress that no proven preventive pharmacologic agents exist, that modification of chemotherapy regimens is the main causal strategy, and that duloxetine offers limited symptomatic benefit when painful CIPN is established, often alongside supportive exercise or rehabilitation interventions.^{[0][16][20][21][24]} Overall, the prevailing view is that clinicians should address known modifiable causes

In their own wordsView sourceArchived copy

“At Amplify Life Center, we treat neuropathy by addressing its root causes, not just masking symptoms”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Neuropathy

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise we’ll take digital X-rays and perform diagnostic testing as within their scope of practice.

we’ll take digital X-rays and perform diagnostic testing

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“we’ll take digital X-rays and perform diagnostic testing”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise one week, one month, or several months as within their scope of practice.

one week, one month, or several months

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“one week, one month, or several months”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise those who received care with the Webster Technique had a 30% decrease in labor times as within their scope of practice.

those who received care with the Webster Technique had a 30% decrease in labor times

Supports

The specific influencer claim is that people receiving care with the Webster Technique had about a 30% decrease in labor times. ^[19][20][22] The peer‑reviewed index items provided do not relate to obstetrics or chiropractic care, so none of them support this claim. Outside those, the main data often cited by chiropractors about shorter labor are older observational or conference-proceeding reports on general chiropractic care in pregnancy (e. ^[21] g. , Fallon’s 1990s work and similar summaries) that suggest labor durations reduced by roughly 24–33% among women receiving chiropractic care compared with historical averages. ^[26] These reports are not randomized controlled trials, are subject to major bias (self-selection, uncontrolled confounders, lack of blinding, nonstandard outcome measures), and they usually refer to general prenatal chiropractic care rather than specifically the Webster Technique. ^[23][24][25] Therefore they provide, at best, very low‑quality, indirect support for the numeric 30% reduction claim rather than high-quality, peer‑reviewed evidence.

Contradicts

High‑quality evidence (randomized trials, systematic reviews) on manipulative therapy in pregnancy shows that the evidence for effects on labor duration is limited and emergent, not robust, and no high‑quality trials specifically evaluate the Webster Technique’s effect on labor length. ^[24][25][26] Narrative and systematic reviews of chiropractic care in pregnancy have found low‑to‑moderate quality evidence focused largely on musculoskeletal pain relief and fetal positioning, with no convincing data that adding chiropractic care, including craniosacral or similar techniques, measurably changes obstetric interventions or labor duration in a reliable way. ^{[19][20][21][23]} Some reviews explicitly state there are no randomized controlled trials of spinal manipulative therapy during pregnancy that demonstrate clear benefits for labor and delivery outcomes, and that claims of improved labor are based on case reports, case series, and uncontrolled observational data. Professional and academic materials addressing the Webster Technique itself note that clinical claims about obstetric outcomes (including labor time changes) are not yet supported by higher levels of evidence such as randomized controlled trials, and that reported benefits are largely empirical or anecdotal. ^[22] Together, this means the specific assertion of a 30% decrease in labor times is not corroborated by robust peer‑reviewed data and may overstate what the current evidence can justify.

Mainstream view

Mainstream obstetrics and evidence‑based medicine do not recognize the Webster Technique as a proven method to shorten labor duration. ^[22][25] Major obstetric and perinatal guidelines (e. g. , ACOG, RCOG and similar bodies) do not recommend the Webster Technique or chiropractic manipulation as an intervention to reduce labor time, primarily because there are no high‑quality randomized trials or large prospective studies demonstrating such an effect. ^{[19][20][21][23][24][26]} The mainstream view is that the Webster Technique may be used by some chiropractors to address maternal musculoskeletal discomfort and theoretically to optimize pelvic mechanics and fetal positioning, but its obstetric outcome claims, including specific percentage reductions in labor duration, are considered unproven and based on low‑quality, anecdotal, or highly biased data. Standard clinical management of labor duration relies on well‑studied interventions (e. g. , oxytocin, amniotomy, analgesia strategies, positioning, and other midwifery and obstetric practices) rather than chiropractic techniques. As a result, the consensus position is that claims of a 30% reduction in labor time from the Webster Technique should be regarded as marketing or hypothesis‑generating rather than established evidence.

In their own wordsView sourceArchived copy

“those who received care with the Webster Technique had a 30% decrease in labor times”

Rule: K.S.A. 65-2871

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure improve my physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment.

improve my physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment

Supports

There is some limited evidence that body posture influences autonomic function and heart rate variability (HRV). A recent systematic review on sedentary lifestyle and spine posture found that seated posture, especially forward trunk flexion, had a measurable impact on HRV and sympathetic tone, suggesting that more neutral, less flexed sitting positions may be associated with a more favorable autonomic profile.^[2][3] Observational and experimental work on posture in both healthy and diseased populations has shown that changing from supine to standing alters HRV spectral measures, indicating that posture can modulate autonomic balance and cardiovascular responses, though this is a normal physiological effect rather than a therapeutic alignment intervention.^[14][8] Some small randomized and quasi-randomized trials of spinal manipulation (chiropractic) report acute reductions in blood pressure and pulse rate after thoracic or cervical adjustments compared with placebo or control, implying a short-term autonomic and hemodynamic effect of certain alignment-focused interventions.^{[4][5][6][10][11][12]} These data collectively support that posture and manipulative interventions targeting spinal alignment can acutely influence measures like blood pressure, heart rate, and HRV, at least in the short term.

Contradicts

High-quality evidence directly showing that “proper alignment” broadly improves sleep, digestion, blood pressure, and HRV in a sustained, clinically meaningful way is lacking. The systematic review on sedentary time, heart rate and HRV found only low-quality evidence for a small, unfavorable association between sedentary time and heart rate and no consistent association with HRV, which weakens strong claims that simple postural correction or reduced sitting will reliably improve HRV in a clinically important way.^[9] In hypertension, randomized clinical trials comparing chiropractic spinal manipulation (an alignment-focused modality) plus diet versus diet alone showed no significant additional reduction in blood pressure from spinal manipulation, indicating no clear advantage of such alignment treatment for chronic blood pressure control.^[1] A sham-controlled pilot trial of upper cervical spinal manipulation found that six weeks of manipulation did not lower systolic or diastolic blood pressure relative to sham, and the authors concluded their results did not support proceeding to a larger clinical trial.^[15] Review articles summarizing the chiropractic–hypertension literature highlight very heterogeneous and small studies, inconsistent results, and overall insufficient evidence to recommend spinal manipulation as a blood-pressure treatment.^[6][12] For HRV, existing posture and sedentary behavior studies show alterations with position and prolonged sitting, but they do not demonstrate that intentional “proper alignment” or chiropractic-type corrections produce durable improvements in HRV or downstream health outcomes.^[2][3][8][9] Regarding sleep and digestion, most rigorous sleep RCTs focus on pharmacologic agents, behavioral therapy, exercise, or neuromodulation (e.g., vagus nerve stimulation) and do not test spinal or postural alignment as primary interventions for sleep quality or gastrointestinal function; there is essentially no high-quality trial evidence that alignment-focused therapies alone meaningfully improve chronic insomnia or digestive disorders compared with standard care.^{[16][19][22][23]} Overall, the evidence base is too sparse, small, and inconsistent to support broad, multi-system physiologic benefits from “proper alignment” as claimed.

Mainstream view

Mainstream medical and scientific opinion accepts that posture and body position influence cardiovascular and autonomic measures (such as blood pressure and HRV) in the short term and that extreme or prolonged poor posture can contribute to musculoskeletal pain and possibly secondary discomfort that may indirectly affect sleep or well-being.^{[2][3][8][14]} However, major hypertension, sleep, and gastrointestinal guidelines do not list spinal or postural “alignment” therapies as evidence-based treatments for chronic hypertension, primary insomnia, or functional digestive disorders, because rigorous randomized trials and large systematic reviews demonstrating clear, durable benefit are lacking.^{[1][6][9][15]} Alignment-based modalities like chiropractic manipulation are viewed as potential options mainly for certain musculoskeletal complaints, with any cardiovascular or sleep effects considered unproven and, at best, secondary or modest. Current consensus is that blood pressure control should rely on lifestyle changes (diet, exercise, weight, alcohol/smoking modification) and pharmacotherapy when indicated; sleep problems should be addressed with behavioral approaches (e.g., CBT for insomnia), timed exercise and light exposure, and medications when appropriate; and digestive issues should be managed with diet, motility/acid-suppressive or other targeted drugs, and psychological therapies where indicated, rather than relying on alignment as a primary physiologic treatment.^{[1][6][9][16][22][23]}

In their own wordsView sourceArchived copy

“Are you looking to improve your physiology (sleep, digestion, blood pressure, heart rate variability) through proper alignment?”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Heart disease and cholesterol

Amelia Rodrock is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Neuropathy 'root cause' treatment.

Neuropathy 'root cause' treatment

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Neuropathy”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Neuropathy